Sustained cognitive decline in HIV infection: Relationship to CD4+ cell count, plasma viremia and p24 antigenemia

Journal of NeuroVirology

Volumn 4, Issue 1, 1998, Pages 95-99

  Dal Pan, Gerald J ^a,d   Farzadegan, Homayoon ^b   Seines, Ola ^a   Hoover, Donald R ^b   Miller, Eric N ^c   Skolasky, Richard L ^a   Nance Sproson, Tish E ^a   McArthur, Justin C ^a,b  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b JOHNS HOPKINS UNIVERSITY   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d JOHNS HOPKINS HOSPITAL   (United States)

Author keywords

Cognition; HIV infection; Neuropsychological tests; Viral load

Indexed keywords

ANTIGEN P24; CD4 ANTIGEN; HEMOGLOBIN;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ARTICLE; BODY MASS; CELL COUNT; COGNITIVE DEFECT; CONTROLLED STUDY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; NEUROPSYCHOLOGICAL TEST; PRIORITY JOURNAL; TASK PERFORMANCE; VIREMIA; VIRUS LOAD;

EID: 0031939651     PISSN: 13550284     EISSN: None     Source Type: Journal    
DOI: 10.3109/13550289809113486     Document Type: Article

References (27)

1. Buffet R, Agut H, Chieze F et al. (1991). Virological markers in the cerebrospinal fluid from HIV-1 infected individuals. AIDS 5: 1419-1424.
2. Centers for Disease Control (1987). Revision of the CDC surveillance case definition for acquired immunodeficiency syndrome. MMWR 36(suppl 1S): 3S-15S.
3. Conrad AJ, Schmid P, Syndulko K et al. (1995). Quantifying HIV-1 RNA using the polymerase chain reaction on cerebrospinal fluid and serum of seropositive individuals with and without neurologic abnormalities. Journal of the Acquired Immunodeficiency Syndrome and Human Retrovirology 10: 425-435.
4. Coombs RW, Collier AC, Allain JP et al. (1989). Plasma viremia in human immunodeficiency virus infection. N Engl J Med 321: 1626-1631.
5. Cornblath DR, McArthur JC (1988) Predominantly sensory neuropathy in patients with AIDS and AIDS-related complex. Neurology 38: 794-796.
6. Dal Pan GJ, Glass JD, McArthur JC (1994). Clinicopathologic correlations of HIV-associated vacuolar myelopathy: An autopsy-based case-control study. Neurology 44: 2159-2164.
7. Farzadegan H, Chmiel JS, Odaka N et al. (1992). Association of antibody to human immunodeficiency virus type 1 core protein (p24), CD4+ lymphocyte number, and AIDS-free time. J Infect Dis 166: 1217-1222.
8. Hinkin CH, VanGorp WG, Satz P, Weisman JD, Thommes J, Buckingham S (1992). Depressed mood and its relationship to neuropsychological test performance in HIV-1 seropositive individuals. J Clin Exp Neuropsychol 14: 289-297.
9. Janssen RS, Cornblath DR, Epstein LG et al. (1991). Nomenclature and research case definitions for neurological manifestations of human immuno-deficiency virus type-1 (HIV-1) infection. Report of a Working Group of the American Academy of Neurology AIDS Task Force. Neurology 41: 778-785.
10. Kaslow RA, Ostrow DG, Detels R, Phair JP, Polk BF, Rinaldo CR (1987). The Multicenter AIDS Cohort Study (MACS): Rationale, organization, and selected characteristics of the participants. Am J Epidemiol 126: 310-318.
11. Kelen GD, Chanmugan A, Meyer WA, Farzedegan H, Stone D, Quinn TC (1993). Detection of HIV-1 polymerase chain reaction and culture in seronegative intravenous drug users in an inner-city emergency department. Ann Emerg Med 22: 769-775.
12. Kewman DG, Vaishampayan N, Zald D, Han B (1991). Cognitive Impairment in musculoskeletal pain patients. Int J Psychiatry Med 21: 253-262.
13. Margolick JB, Farzadegan H, Hoover DR, Saah AJ (1996). Relationship between infectious cell-associated human immunodeficiency virus type 1 load, T lymphocyte subsets, and stage of infection in homosexual men. J Infect Dis 173: 468-471.
14. Mayeux R, Stern Y, Tang MX et al. (1993). Mortality risks in gay men with human immunodeficiency virus infection and cognitive impairment. Neurology 43: 176-182.
15. McArthur JC (1987). Neurologic manifestations of AIDS. Medicine (Baltimore) 66: 407-437.
16. McArthur JC, Hoover DR, Bacellar H et al. (1993). Dementia in AIDS patients: incidence and risk factors. Neurology 43: 2245-2253.
17. Mellors JW, Kingsley LA, Rinaldo CR et al. (1995). Quantitation of HIV-1 RNA in plasma predicts outcome after seroconversion. Ann Intern Med 122: 573-579.
18. Miller RG, Carson PJ, Moussavi RS, Green AT, Baker AJ, Weiner MW (1991). Fatigue and myalgia in AIDS patients. Neurology 41: 1603-1607.
19. Pantaleo G, Graziosi C, Butini L et al. (1991). Lymphoid organs function as major reservoirs for human immunodeficiency virus. Proc Natl Acad Sci USA 88: 9838-9842.
20. Royal W, Seines OA, Concha M, Nance-Sproson TE, McArthur JC (1994). Cerebrospinal fluid HIV-1 p24 antigen levels in HIV-1-related dementia. Ann Neurol 36: 32-39.
21. Sacktor NC, Bacellar H, Hoover DR et al. (1996) Psychomotor slowing in HIV infection: a predictor of dementia, AIDS and death. J Neurovirol 2: 404-410.
22. Schmid P, Conrad AJ, Syndulko K et al. (1994). Quantifying HIV-1 proviral DNA using the polymerase chain reaction on cerebrospinal fluid and blood of seropositive individuals with and without neurologic abnormalities. J Acquir Immune Defic Svndr 7: 777-788.
23. Schooley RT (1995). Correlation between viral load measurements and outcome in clinical trials of antiviral drugs. AIDS 9 (Suppl): S15-S19.
24. Seines OA, Miller E, McArthur JC et al. (1990). HIV-1 infection: No evidence of cognitive decline during the asymptomatic stages. Neurology 40: 204-208.
25. Seines OA, Miller EN (1994). Development of a screening battery for HIV-related cognitive impairment: the MACS experience. Neuropsychology of HIV Infection: Current Research and New Directions; Grant I, Martin A, (eds). Oxford University Press: New York: pp 176-187.
26. Sidtis JJ, Gatsonis C, Price RW et al. (1993). Zidovudine Treatment of the AIDS Dementia Complex: Results of a Placebo-Controlled Trial. Am Neurol 33: 343-349.
27. Singer EJ, Syndulko K, Fahy-Chandon BN et al. (1994). Cerebrospinal fluid p24 antigen levels and intrathecal immunoglobulin G synthesis are associated with cognitive disease severity in HIV-1. AIDS 8: 197-204.